首页> 外国专利> SYSTEMS AND METHODS FOR DETERMINING THE BENEFICIAL ADMINISTRATION OF TUMOR INFILTRATING LYMPHOCYTES, AND METHODS OF USE THEREOF AND BENEFICIAL ADMINISTRATION OF TUMOR INFILTRATING LYMPHOCYTES, AND METHODS OF USE THEREOF

SYSTEMS AND METHODS FOR DETERMINING THE BENEFICIAL ADMINISTRATION OF TUMOR INFILTRATING LYMPHOCYTES, AND METHODS OF USE THEREOF AND BENEFICIAL ADMINISTRATION OF TUMOR INFILTRATING LYMPHOCYTES, AND METHODS OF USE THEREOF

机译:测定肿瘤浸润性淋巴细胞的有益管理的系统和方法,及其使用方法和肿瘤浸润性淋巴细胞的有益管理,及其使用方法

摘要

The invention provides systems and methods for determining and predicting the effect of providing a population of tumor infiltrating lymphocytes (TILs) on a condition associated with an entity, for example the effect of providing a population of tumor infiltrating lymphocytes (TILs) on a subject having cancer. The systems and methods rely on acquiring a computer readable analytical signature from a sample of the entity, obtaining a trained model output value for the entity by inputting the computer readable analytical signature into a tier trained model panel, and classifying the entity based upon the trained model output value with a time-to-event class in an enumerated set of time-to-event classes, each of whom is associated with a different effect of providing a population of TILs to the entity. The invention provides methods of treating cancer in a patient by administering a therapeutically effective population of TILs to the patient, which is at the same determined to be likely to benefit from the administration of TILs comparative to other cancer patients that have been administered TILs. Such methods of treatment include obtaining from the patient a tumor fragment, contacting the tumor fragment with one or more cell culture mediums, thereby performing one or more expansions of population of TILs existing in the tumor, and producing one or more subsequent populations of TILs. The invention also provides methods of treating cancer in a patient exhibiting an increased or decreased level of expression of various biological markers.
机译:本发明提供了用于确定和预测在与实体相关的状况下提供肿瘤浸润淋巴细胞(TILs)群体的效果的系统和方法,例如对患有以下疾病的受试者提供肿瘤浸润淋巴细胞(TILs)群体的效果癌症。所述系统和方法依赖于从实体的样本获取计算机可读分析签名,通过将计算机可读分析签名输入到经层训练的模型面板中来获得实体的经训练的模型输出值,以及基于经训练的模型对实体进行分类。在列举的事件时间类集中使用事件时间类对模型输出值进行建模,每个事件类都与向实体提供大量TIL的不同效果相关联。本发明提供了通过向患者施用治疗有效的TIL群体来治疗患者的癌症的方法,与已经施用TIL的其他癌症患者相比,该群体被确定为可能从施用TIL中受益。此类治疗方法包括从患者获得肿瘤片段,使肿瘤片段与一种或多种细胞培养基接触,从而进行肿瘤中存在的TIL群体的一种或多种扩增,并产生一个或多个随后的TIL群体。本发明还提供了治疗表现出各种生物标志物表达水平升高或降低的患者癌症的方法。

著录项

  • 公开/公告号WO2019118873A2

    专利类型

  • 公开/公告日2019-06-20

    原文格式PDF

  • 申请/专利权人 IOVANCE BIOTHERAPEUTICS INC.;

    申请/专利号WO2018US65745

  • 申请日2018-12-14

  • 分类号G16H10;G01N33/574;G01N33/68;G16B20;G16B40/10;

  • 国家 WO

  • 入库时间 2022-08-21 11:54:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号